HRC Ledger
Opportunity

3D Imaging Microscope System

Response due

September 14, 2026

Agency
FDA Office of Acq Grant Svcs
Estimated value
Not stated
SCOPE I. Minimum Performance Requirements/Salient Characteristics Salient Characteristics The contractor shall provide all resources necessary to accomplish the tasks and deliverables described in this statement of work, including the hardware system requirements which are the minimum requirements. Equivalent requirements that differ from these minimum requirements must be justified by the proposing vendor and evaluated by the NFCC prior to purchase. 1.0 General Requirement The National Forensic Chemistry Center (NFCC) requires a Bruker Alicona InfiniteFocus G6 (IFM G6) optical 3D measurement system. This non-contact, optical 3D imaging and measurement system will be used by NFCC's Trace Examination Section (TES) for surface profilometry and difference analysis measurements, including tablet debossing, punch face embossing, surface abrasion, pit measurements, corroded surface analysis, and pharmaceutical packaging topography and print profiling. The system must expand analytical throughput to meet increasing demand for forensic 3D image analysis from law enforcement stakeholders. 2.0 Core Technology and Measurement Principle 2.1 The system shall be based on the principle of Focus Variation Microscopy (FVM), utilizing Bruker Alicona's proprietary Focus Variation algorithms to reconstruct high-resolution 3D surfaces. 2.2 The system must include advanced illumination technology (e.g., ring light, coaxial light) to enable accurate measurement of surfaces with steep angles, up to and exceeding 85 degrees. 2.3 The system must be capable of measuring both form and surface roughness parameters in a single measurement, with all data being co-registered. 2.4 The system must have the ability to measure highly reflective materials without surface treatment. The system must be capable of acquiring accurate 3D topographic data on reflective and specular materials without requiring surface alteration that could compromise the integrity of forensic samples. 2.5 The system must have the capability to capture true-color optical data co-registered with 3D topography. This capability supports surface characterization, documentation, and interpretation of coating or material variations. Many profilometry systems such as systems that use laser or tip technologies do not provide integrated true-color 3D datasets.

Key dates

Posted
September 8, 2026
Response due
September 14, 2026

Organization

FDA OFFICE OF ACQ GRANT SVCS

Buying history

  • Records104 total
  • Opportunities / awards0 / 16
  • Value range$305 – $10,856,214
  • ActiveJuly 17, 2026 – October 17, 2026

What they buy

  • Clinical (96)
  • Administrative (8)

Set-asides used

  • No Set aside used (57)
  • Small Business Set Aside - Total (13)
  • 8(a) Set-Aside (FAR 19.8) (1)
  • 8(a) Sole Source (FAR 19.8) (1)

Who holds their work today

  1. EAGLE HEALTH, LLC2 wins · $15,051,897 · last February 27, 2023
  2. SERVEFED INC.1 win · $10,844,558 · last July 12, 2024
  3. UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES3 wins · $285,145 · last July 18, 2025
  4. KATMAI COMMODITIES, LLC1 win · $104,123 · last May 16, 2023
  5. STEMEXPRESS, LLC2 wins · $98,658 · last September 6, 2024
View source document →

Source link on sam.gov.

Source record

Buyer type
Federal
Jurisdiction
Federal (US)
Category
Clinical
Set-aside
No Set aside used
NAICS
334519
PSC
6640